Differential Expression of PKD2-Associated Genes in Autosomal Dominant Polycystic Kidney Disease

Yeon Joo Yook1, Yu Mi Woo, Moon Hee Yang

  • 1Department of Biological Science, Sookmyung Women's University, Seoul 140-742, Korea.

Genomics & Informatics
|October 30, 2012
PubMed

Insights

Mutations in PKD genes cause autosomal dominant polycystic kidney disease (ADPKD), leading to kidney cyst formation. This study investigates PKD2

Area of Science:

  • Nephrology and Molecular Biology
  • Genetics and Developmental Biology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by kidney cyst development, often caused by mutations in PKD1 or PKD2 genes.
  • The precise roles of PKD1 and PKD2 proteins in renal tubular development and the cellular mechanisms underlying ADPKD cystogenesis remain incompletely understood.
  • Previous mouse models highlighted the critical importance of PKD1 and PKD2 during kidney development, but detailed molecular pathways are yet to be elucidated.

Purpose of the Study:

  • To investigate the cellular mechanisms and molecular pathways involved in cyst formation in ADPKD by examining the role of PKD2.
  • To identify genes and biological processes affected by altered PKD2 expression levels in the context of ADPKD.
  • To provide insights into PKD2-related pathogenesis for potential therapeutic targets in ADPKD.

Main Methods:

  • Generation of Pkd2 knockout and PKD2 transgenic mouse embryo fibroblasts.
  • Utilized mouse oligonucleotide microarrays to analyze messenger RNA (mRNA) expression profiles.
  • Compared gene expression patterns in cells with altered Pkd2 status to identify differentially expressed genes.

Main Results:

  • Microarray analysis identified numerous differentially expressed genes in response to Pkd2 knockout or overexpression.
  • Affected genes were predominantly involved in critical cellular processes including metabolism, transcription, cell adhesion, cell cycle, and signal transduction.
  • Confirmed differential expression of specific genes, such as aquaporin-1, correlating with varying PKD2 expression levels in ADPKD mouse models.

Conclusions:

  • Altered PKD2 expression significantly impacts a wide range of cellular functions, contributing to ADPKD pathogenesis.
  • The identified differentially expressed genes provide potential molecular targets for understanding and treating ADPKD.
  • These findings offer valuable data for elucidating PKD2-mediated mechanisms in the development of autosomal dominant polycystic kidney disease.

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...